Evidence supporting an association between expression of major histocompatibility complex II by microglia and optic nerve degeneration during experimental glaucoma

Journal of Glaucoma

Volumn 25, Issue 8, 2016, Pages 681-691

  Chidlow, Glyn ^a,b   Ebneter, Andreas ^c   Wood, John P M ^a,b   Casson, Robert J ^a,b  

^a HANSON INSTITUTE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Major histocompatibility complex; Microglia; Neurodegeneration; Optic nerve

Indexed keywords

CD74 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENDOTOXIN-INDUCED UVEITIS; EXPERIMENTAL GLAUCOMA; FEMALE; GLIOSIS; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MICROGLIA; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NONHUMAN; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA GANGLION CELL; UPREGULATION; UVEA; ANIMAL; DISEASE MODEL; GENE; GLAUCOMA; MALE; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TRABECULAR MESHWORK;

ANIMALS; DISEASE MODELS, ANIMAL; GENES, MHC CLASS II; GLAUCOMA; INTRAOCULAR PRESSURE; MALE; MICROGLIA; NERVE DEGENERATION; OPTIC NERVE DISEASES; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS; TRABECULAR MESHWORK; UVEA;

EID: 84973154641     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0000000000000447     Document Type: Article

References (45)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90:262-267.
2. Casson RJ, Chidlow G, Wood JP, et al. Definition of glaucoma: clinical and experimental concepts. Clin Experiment Ophthalmol. 2012;40:341-349.
3. Chong RS, Martin KR. Glial cell interactions and glaucoma. Curr Opin Ophthalmol. 2015;26:73-77.
4. Seitz R, Ohlmann A, Tamm ER. The role of Muller glia and microglia in glaucoma. Cell Tissue Res. 2013;353:339-345.
5. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10:1387-1394.
6. Johnson EC, Morrison JC. Friend or foe? Resolving the impact of glial responses in glaucoma. J Glaucoma. 2009;18: 341-353.
7. Wang JW, Chen SD, Zhang XL, et al. Retinal microglia in glaucoma. J Glaucoma. 2016;25:459-465.
8. Bosco A, Steele MR, Vetter ML. Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol. 2011;519: 599-620.
9. Bosco A, Romero CO, Breen KT, et al. Neurodegeneration severity is anticipated by early microglia alterations monitored in vivo in a mouse model of chronic glaucoma. Dis Model Mech. 2015;8:443-455.
10. Levkovitch-Verbin H, Kalev-Landoy M, Habot-Wilner Z, et al. Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection. Arch Ophthalmol. 2006;124:520-526.
11. Bosco A, Inman DM, Steele MR, et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2008;49: 1437-1446.
12. Wang K, Peng B, Lin B. Fractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model. Glia. 2014;62:1943-1954.
13. Bosco A, Crish SD, Steele MR, et al. Early reduction of microglia activation by irradiation in a model of chronic glaucoma. PLoS One. 2012;7:e43602.
14. Howell GR, Soto I, Zhu X, et al. Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J Clin Invest. 2012;122:1246-1261.
15. Perry VH. A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. J Neuroimmunol. 1998;90: 113-121.
16. Harnesk K, Swanberg M, Ockinger J, et al. Vra4 congenic rats with allelic differences in the class II transactivator gene display altered susceptibility to experimental autoimmune encephalomyelitis. J Immunol. 2008;180:3289-3296.
17. Piehl F, Swanberg M, Lidman O. The axon reaction: identifying the genes that make a difference. Physiol Behav. 2007;92:67-74.
18. Dominguez CA, Lidman O, Hao JX, et al. Genetic analysis of neuropathic pain-like behavior following peripheral nerve injury suggests a role of the major histocompatibility complex in development of allodynia. Pain. 2008;136:313-319.
19. Tompkins SM, Padilla J, Dal Canto MC, et al. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J Immunol. 2002;168:4173-4183.
20. Matsushima GK, Taniike M, Glimcher LH, et al. Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell. 1994;78:645-656.
21. Harms AS, Cao S, Rowse AL, et al. MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci. 2013;33:9592-9600.
22. Ebneter A, Casson RJ, Wood JP, et al. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest Ophthalmol Vis Sci. 2010;51:6448-6460.
23. Levkovitch-Verbin H, Quigley HA, Martin KR, et al. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest Ophthalmol Vis Sci. 2002;43: 402-410.
24. Chidlow G, Daymon M, Wood JP, et al. Localization of a wide-ranging panel of antigens in the rat retina by immunohistochemistry: comparison of Davidson's solution and formalin as fixatives. J Histochem Cytochem. 2011;59:884-898.
25. Chidlow G, Ebneter A, Wood JP, et al. The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma. Acta Neuropathol. 2011;121:737-751.
26. Ebneter A, Chidlow G, Wood JP, et al. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma. Arch Ophthalmol. 2011; 129:1337-1344.
27. Ebneter A, Casson RJ, Wood JP, et al. Estimation of axon counts in a rat model of glaucoma: comparison of fixed-pattern sampling with targeted sampling. Clin Experiment Ophthalmol. 2012;40:626-633.
28. Kim MK, Palestine AG, Nussenblatt RB, et al. Expression of class II antigen in endotoxin induced uveitis. Curr Eye Res. 1986;5:869-876.
29. Pease ME, Zack DJ, Berlinicke C, et al. Effect of CNTF on retinal ganglion cell survival in experimental glaucoma. Invest Ophthalmol Vis Sci. 2009;50:2194-2200.
30. Bull ND, Irvine KA, Franklin RJ, et al. Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma. Invest Ophthalmol Vis Sci. 2009;50:4244-4253.
31. Lundberg C, Lidman O, Holmdahl R, et al. Neurodegeneration and glial activation patterns after mechanical nerve injury are differentially regulated by non-MHC genes in congenic inbred rat strains. J Comp Neurol. 2001;431:75-87.
32. Howell GR, Libby RT, Jakobs TC, et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol. 2007;179:1523-1537.
33. Johnson EC, Jia L, Cepurna WO, et al. Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci. 2007;48:3161-3177.
34. Lam TT, Kwong JM, Tso MO. Early glial responses after acute elevated intraocular pressure in rats. Invest Ophthalmol Vis Sci. 2003;44:638-645.
35. Baptiste DC, Powell KJ, Jollimore CA, et al. Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy. Neuroscience. 2005;134:575-582.
36. Wang J, Chen S, Zhang X, et al. Intravitreal triamcinolone acetonide, retinal microglia and retinal ganglion cell apoptosis in the optic nerve crush model. Acta Ophthalmol. 2015. [Epub ahead of print].
37. Shimazawa M, Yamashima T, Agarwal N, et al. Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage. Brain Res. 2005;1053:185-194.
38. Mathalone N, Lahat N, Rahat MA, et al. The involvement of matrix metalloproteinases 2 and 9 in rat retinal ischemia. Graefes Arch Clin Exp Ophthalmol. 2007;245:725-732.
39. Nikodemova M, Watters JJ, Jackson SJ, et al. Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII. J Biol Chem. 2007;282:15208-15216.
40. Slavin AJ, Soos JM, Stuve O, et al. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J Clin Invest. 2001;108: 1133-1139.
41. Flugel A, Berkowicz T, Ritter T, et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity. 2001;14:547-560.
42. Bell K, Gramlich OW, Von Thun Und Hohenstein-Blaul N, et al. Does autoimmunity play a part in the pathogenesis of glaucoma? Prog Retin Eye Res. 2013;36:199-216.
43. Piehl F, Lundberg C, Khademi M, et al. Non-MHC gene regulation of nerve root injury induced spinal cord inflammation and neuron death. J Neuroimmunol. 1999;101:87-97.
44. Lidman O, Swanberg M, Horvath L, et al. Discrete gene loci regulate neurodegeneration, lymphocyte infiltration, and major histocompatibility complex class II expression in the CNS. J Neurosci. 2003;23:9817-9823.
45. Diez M, Abdelmagid N, Harnesk K, et al. Identification of gene regions regulating inflammatory microglial response in the rat CNS after nerve injury. J Neuroimmunol. 2009;212: 82-92.